Direk Meltem Çobanoğulları, Besen Şeyda, Öncel İbrahim, Günbey Ceren, Özdoğan Orhan, Orgun Leman Tekin, Sahin Sevim, Cansu Ali, Yıldız Nihal, Kanmaz Seda, Yılmaz Sanem, Tekgül Hasan, Türkdoğan Dilşad, Ünver Olcay, Thomas Gülten Öztürk, Başıbüyük Salih, Yılmaz Deniz, Kurt Ayşegül Neşe, Gültutan Pembe, Özsoy Özlem, Yiş Uluç, Kurul Semra Hız, Güngör Serdal, Özgör Bilge, Karadağ Meral, Dündar Nihal Olgaç, Gençpınar Pınar, Bildik Olgay, Orak Sibğatullah Ali, Kabur Çişil Çerçi, Kara Bülent, Karaca Ömer, Canpolat Mehmet, Gümüş Hakan, Per Hüseyin, Yılmaz Ünsal, Karaoğlu Pakize, Ersoy Özlem, Tosun Ayşe, Öztürk Semra Büyükkorkmaz, Yüksel Deniz, Atasoy Ergin, Gücüyener Kıvılcım, Yıldırım Miraç, Bektaş Ömer, Çavuşoğlu Dilek, Yarar Çoşkun, Güngör Olcay, Mert Gülen Gül, Sarıgeçili Esra, Edizer Selvinaz, Çetin İpek Dokurel, Aydın Seren, Diler Betül, Özdemir Asena Ayça, Erol İlknur, Okuyaz Çetin, Anlar Banu
Department of Pediatrics, Division of Pediatric Neurology, Mersin University Faculty of Medicine, Faculty Of Medicine, 34, Cadde, Çiftlikköy Kampüsü, Mersin 33343, Türkiye.
Department of Pediatrics, Division of Pediatric Neurology, Başkent University Faculty of Medicine, Adana, Türkiye.
Mult Scler Relat Disord. 2024 Jan;81:105149. doi: 10.1016/j.msard.2023.105149. Epub 2023 Nov 26.
Various etiologies may underlie optic neuritis, including autoantibody-mediated disorders described in the last decade. We re-examined demographic, clinical, laboratory features and prognostic factors in pediatric patients with autoimmune optic neuritis according to current knowledge.
Cases of pediatric ON from 27 centers in Türkiye diagnosed between 2009 and 2022 were included for retrospective evaluation.
The study included 279 patients, 174 females and 105 males, with a female-to-male ratio of 1.65. The average age at onset was 12.8 ± 3.4 years, and mean follow-up, 2.1 years (range: 1-12.1 years). Patients <10 years old were grouped as "prepubertal" and those ≥10 years old as "others". The diagnoses made at the end of follow-up were multiple sclerosis associated optic neuritis (n = 90, 32.3 %), single isolated optic neuritis (n = 86, 31 %), clinically isolated syndrome (n = 41, 14.7 %), myelin oligodendrocyte glycoprotein antibody associated optic neuritis (n = 22, 7.9 %), and relapsing isolated optic neuritis (n = 18, 6.5 %). Predominant diagnoses were myelin oligodendrocyte glycoprotein antibody associated optic neuritis and acute disseminated encephalomyelitis associated optic neuritis in the prepubertal group and multiple sclerosis associated optic neuritis in the older group. Recurrences were observed in 67 (24 %) patients, including 28 with multiple sclerosis associated optic neuritis, 18 with relapsing isolated optic neuritis, 11 with myelin oligodendrocyte glycoprotein antibody associated optic neuritis, 8 with aquaporin-4 antibody related optic neuritis, and 2 with chronic relapsing inflammatory optic neuropathy. Recurrences were more common among female patients. Findings supporting the diagnosis of multiple sclerosis included age of onset ≥ 10 years (OR=1.24, p = 0.027), the presence of cranial MRI lesions (OR=26.92, p<0.001), and oligoclonal bands (OR=9.7, p = 0.001). Treatment in the acute phase consisted of intravenous pulse methylprednisolone (n = 46, 16.5 %), pulse methylprednisolone with an oral taper (n = 212, 76 %), and combinations of pulse methylprednisolone, plasmapheresis, or intravenous immunoglobulin (n = 21, 7.5 %). Outcome at 12 months was satisfactory, with 247 out of 279 patients (88.5 %) demonstrating complete recovery. Thirty-two patients exhibited incomplete recovery and further combination treatments were applied. Specifically, patients with relapsing isolated optic neuritis and aquaporin-4 antibody related optic neuritis displayed a less favorable prognosis.
Our results suggest optic neuritis is frequently bilateral in prepubertal and unilateral in peri‑ or postpubertal patients. Age of onset 10 or older, presence of oligoclonal bands, and brain MRI findings reliably predict the development of multiple sclerosis. The risk of developing multiple sclerosis increases mostly during the second and third years of follow-up. Relapsing isolated optic neuritis remains a separate group where the pathogenesis and outcome remain unclear. Investigation of predisposing and diagnostic biomarkers and long follow-up could help to define this group.
多种病因可能导致视神经炎,包括过去十年中描述的自身抗体介导的疾病。我们根据当前知识重新审视了自身免疫性视神经炎患儿的人口统计学、临床、实验室特征及预后因素。
纳入2009年至2022年间土耳其27个中心诊断的儿童视神经炎病例进行回顾性评估。
该研究纳入了279例患者,其中女性174例,男性105例,男女比例为1.65。平均发病年龄为12.8±3.4岁,平均随访时间为2.1年(范围:1 - 12.1年)。<10岁的患者被归为“青春期前”组,≥10岁的患者归为“其他”组。随访结束时的诊断包括多发性硬化相关视神经炎(n = 90,32.3%)、单纯性孤立性视神经炎(n = 86,31%)、临床孤立综合征(n = 41,14.7%)、髓鞘少突胶质细胞糖蛋白抗体相关视神经炎(n = 22,7.9%)和复发性孤立性视神经炎(n = 18,6.5%)。青春期前组的主要诊断为髓鞘少突胶质细胞糖蛋白抗体相关视神经炎和急性播散性脑脊髓炎相关视神经炎,年龄较大组的主要诊断为多发性硬化相关视神经炎。67例(24%)患者出现复发,其中28例为多发性硬化相关视神经炎,18例为复发性孤立性视神经炎,11例为髓鞘少突胶质细胞糖蛋白抗体相关视神经炎,8例为水通道蛋白4抗体相关视神经炎,2例为慢性复发性炎性视神经病变。复发在女性患者中更常见。支持多发性硬化诊断的发现包括发病年龄≥10岁(OR = 1.24,p = 0.027)、头颅MRI病变的存在(OR = 26.92,p < 0.001)和寡克隆带(OR = 9.7,p = 0.001)。急性期治疗包括静脉注射脉冲甲基泼尼松龙(n = 46,16.5%)、脉冲甲基泼尼松龙联合口服递减(n = 212,76%)以及脉冲甲基泼尼松龙、血浆置换或静脉注射免疫球蛋白联合治疗(n = 21,7.5%)。12个月时的结果令人满意,279例患者中有247例(88.5%)完全恢复。32例患者恢复不完全,采用了进一步的联合治疗。具体而言,复发性孤立性视神经炎和水通道蛋白4抗体相关视神经炎患者的预后较差。
我们的结果表明,视神经炎在青春期前患儿中常为双侧性,在青春期或青春期后患者中常为单侧性。发病年龄10岁及以上、寡克隆带的存在以及脑部MRI表现可可靠地预测多发性硬化的发生。多发性硬化的发病风险主要在随访的第二和第三年增加。复发性孤立性视神经炎仍然是一个独立的组,其发病机制和预后尚不清楚。对易感和诊断生物标志物的研究以及长期随访可能有助于明确该组疾病。